AU2020315214B2 — Pharmaceutical composition of temozolomide.
Assigned to Intas Pharmaceuticals Ltd · Expires 2026-02-05 · 0y expired
What this patent protects
The present invention relates to the stable pharmaceutical composition of temozolomide for oral administration. The said pharmaceutical composition is in the form of powder for oral suspension, wherein the said powder is reconstituted with a liquid vehicle just before administrat…
USPTO Abstract
The present invention relates to the stable pharmaceutical composition of temozolomide for oral administration. The said pharmaceutical composition is in the form of powder for oral suspension, wherein the said powder is reconstituted with a liquid vehicle just before administration. Further the invention relates to process for the preparation of said pharmaceutical composition and its use thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.